STING trafficking as a new dimension of immune signaling
Journal of Experimental Medicine · 06.03.2023 · 220 (3)
DOI: 10.1084/jem.20220990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 27.01.2023. Verfasst von Devon Jeltema und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, UT Southwestern Medical Center , Dallas, TX, USA. Hauptthemen laut MEDLINE: Immunity, Innate, Membrane Proteins. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The cGAS–STING pathway is an evolutionarily conserved immune signaling pathway critical for microbial defense. Unlike other innate immune pathways that largely rely on stationary cascades of signaling events, STING is highly mobile in the cell. STING is activated on the ER, but only signals after it arrives on the Golgi, and then it is quickly degraded by the lysosome. Each step of STING trafficking through the secretory pathway is regulated by host factors. Homeostatic STING trafficking via COPI-, COPII-, and clathrin-coated vesicles is important for maintaining baseline tissue and cellular immunity. Aberrant vesicular trafficking or lysosomal dysfunction produces an immune signal through STING, which often leads to tissue pathology in mice and humans. Many trafficking-mediated diseases of STING signaling appear to impact the central nervous system, leading to neurodegeneration. Therefore, STING trafficking introduces a new dimension of immune signaling that likely has broad implications in human disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, UT Southwestern Medical Center , Dallas, TX, USA.
ORCID-Profile: Devon Jeltema, Kennady Abbott, Nan Yan
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- National Institutes of Health
- University of Texas Southwestern Immunology T32 training
- Cancer Prevention and Research Institute of Texas
- Grace Science Foundation
- Ara Parseghian Medical Research Fund
Zitieren
APA
Jeltema, D., Abbott, K., & Yan, N. (2023). STING trafficking as a new dimension of immune signaling. Journal of Experimental Medicine, 220(3). https://doi.org/10.1084/jem.20220990
Vancouver
Jeltema D, Abbott K, Yan N. STING trafficking as a new dimension of immune signaling. Journal of Experimental Medicine. 2023;220(3). doi:10.1084/jem.20220990
BibTeX
@article{Jeltema2023,
author = {Jeltema, Devon and Abbott, Kennady and Yan, Nan},
title = {STING trafficking as a new dimension of immune signaling},
journal = {Journal of Experimental Medicine},
year = {2023},
volume = {220},
number = {3},
doi = {10.1084/jem.20220990}
}
EUVIMED